Skip to main content

Advertisement

Table 1 Patient demographics

From: Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

  Cases (n = 83) Controls (n = 110)
Gendera
 Male 68 (81.9%) 62 (56.4%)
 Female 15 (18.1%) 48 (43.6%)
Ageb
 Median 69 61
 Range 42–88 24–88
Smoking statusc
 Yes 74 (89.2%) 62 (66%)
 No 9 (10.8%) 32 (33%)
Diagnosis
 Healthy   35
 Benign Pathology   75
  RI   53 (70.7%)
  ILD   17 (22.6%)
  Nodule   4 (5.3%)
  ICC   1 (1.3%)
 NSCLC Histology
  ADC 40 (48.2%)  
  SCC 26 (31.3%)  
  LCC 14 (16.9%)  
  BAC 2 (2.4%)  
  ND 1 (1.2%)  
 NSCLC Stage
  I 18 (21.7%)  
  II 6 (7.2%)  
  III 22 (26.5%)  
  IV 37 (44.6%)  
  1. RI Respiratory Infection, ILD Interstitial Lung Disease, ICC Congestive Heart Failure, NSCLC Non-Small Cell Lung Cancer, ADC Adenocarcinoma, SCC Squamous Cell Carcinoma, LCC Large Cell Carcinoma, BAC Bronchioloalveolar Carcinoma, ND Not Differentiated Carcinoma
  2. aGender distribution between cancer and controls statistically significant: P < 0.001 (Fisher test)
  3. bStatistically significant differences in age between cancer and controls: P = 0.001 (Mann-Whitney U test)
  4. cSmoking status distribution between cancer and controls statistically different: P < 0.001 (Fisher test)